|
|
| Addressing The Challenge Of Scalability In Viral Vectors | Gene therapies have delivered remarkable outcomes for patients with a wide variety of diseases and conditions. As the opportunities to improve patient outcomes through these therapies rapidly expand, more efficient methods for upstream viral vector production are needed. Explore different methods for increasing vector productivity and ensuring robust scalability of upstream processes here. |
|
|
|
|
By Life Science Connect Editorial Staff | J. Andrew Case, head of supply chain – Cell & Gene Therapies at Genentech, and Daniel Getts, CEO and cofounder of Myeloid Therapeutics explore raw material issues and the importance of meeting efficient scale-out and turnaround times. |
|
|
|
During this Cell & Gene Live episode, expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more. |
|
|
|
| Move Your Gene Therapy From Strategy To Reality | Article | Cytiva | Implementing integrated solutions can provide cell and gene therapy manufacturing systems that work in concert to create a closed, automated, scalable, and performance-qualified network of unit operations. |
|
|
|
|
|
|
|
|
|
| Expansion Of DF-1 Cell Line In A Circulation/Perfusion System | Application Note | By Ann Rossi Bilodeau and Ann Ferrie, Corning Life Sciences | This study establishes basic cell culture parameters for expansion of DF-1 cells in the Corning CellCube System — a compact and scalable method for mass culture of attachment-dependent cells. |
|
|
|
|
| Powerful Batch Visualization Solution | Infographic | Honeywell Process Solutions | Explore the offerings of a powerful batch solution that dramatically increases operator productivity and enables distributed batch control for a smarter approach to unit operations. |
|
|
|
|
|
| Stem cells are the backbone of many allogeneic therapies and where they come from affects development and supply chain logistics, particularly cryopreservation. What temperatures are ideal to maintain product potency? How do you build a reliable cold chain? How do you work with existing infrastructure to allow for an “off-the-shelf” therapy? Don’t miss the next Cell & Gene Live digital event! Registration is free thanks to the support of Charter Medical and Bio-Techne. |
|
|
|
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|